Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah K Tate

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature Genetics|October 28, 2004
Will tomorrow's medicines work for everyone?Sarah K Tate, David B Goldstein
Expert Opinion on Pharmacotherapy|July 31, 2007
Multidrug resistance in epilepsy: a pharmacogenomic updateSarah K Tate, Sanjay M Sisodiya
Nature Reviews. Genetics|November 25, 2003
Pharmacogenetics goes genomicDavid B Goldstein, Sarah K Tate, Sanjay M Sisodiya
American Journal of Human Genetics|April 17, 2007
Nova2 interacts with a cis-acting polymorphism to influence the proportions of drug-responsive splice variants of SCN1AErin L Heinzen, Woohyun Yoon, Sarah K Tate, et al.
Pharmacogenetics and Genomics|September 27, 2006
A common polymorphism in the SCN1A gene associates with phenytoin serum levels at maintenance doseSarah K Tate, Rinki Singh, Chin-Chuan Hung, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2005
Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoinSarah K Tate, Chantal Depondt, Sanjay M Sisodiya, et al.
The Lancet. Neurology|October 5, 2007
Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control studyGianpiero L Cavalleri, Michael E Weale, Kevin V Shianna, et al.
Brain : a Journal of Neurology|June 5, 2010
Common genetic variation and susceptibility to partial epilepsies: a genome-wide association studyDalia Kasperaviciūte, Claudia B Catarino, Erin L Heinzen, et al.
American Journal of Human Genetics|April 20, 2010
Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromesErin L Heinzen, Rodney A Radtke, Thomas J Urban, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature Genetics|October 28, 2004
Will tomorrow's medicines work for everyone?Sarah K Tate, David B Goldstein
Expert Opinion on Pharmacotherapy|July 31, 2007
Multidrug resistance in epilepsy: a pharmacogenomic updateSarah K Tate, Sanjay M Sisodiya
Nature Reviews. Genetics|November 25, 2003
Pharmacogenetics goes genomicDavid B Goldstein, Sarah K Tate, Sanjay M Sisodiya
American Journal of Human Genetics|April 17, 2007
Nova2 interacts with a cis-acting polymorphism to influence the proportions of drug-responsive splice variants of SCN1AErin L Heinzen, Woohyun Yoon, Sarah K Tate, et al.
Pharmacogenetics and Genomics|September 27, 2006
A common polymorphism in the SCN1A gene associates with phenytoin serum levels at maintenance doseSarah K Tate, Rinki Singh, Chin-Chuan Hung, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2005
Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoinSarah K Tate, Chantal Depondt, Sanjay M Sisodiya, et al.
The Lancet. Neurology|October 5, 2007
Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control studyGianpiero L Cavalleri, Michael E Weale, Kevin V Shianna, et al.
Brain : a Journal of Neurology|June 5, 2010
Common genetic variation and susceptibility to partial epilepsies: a genome-wide association studyDalia Kasperaviciūte, Claudia B Catarino, Erin L Heinzen, et al.
American Journal of Human Genetics|April 20, 2010
Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromesErin L Heinzen, Rodney A Radtke, Thomas J Urban, et al.
Pageof 1